aod9604 side effects safety profile Peptide Spotlight: AOD 9604 — The Wellness Lounge AOD9604 PEPTIDE LIQUID SPRAY 15ML

Body weight, first thing in the morning after using the bathroom, same scale every time

The human clinical data supporting AOD-9604 is limited compared to GLP-1 agonists

While safety monitoring was comprehensive, the trials were not specifically designed to detect rare adverse effects that might occur at rates lower than 1-2%, which would require much larger participant numbers

Each ml Contains : Cyanocobalamin 1000Mcg, Benzyl Alcohol 1.5%, Sodium Chloride for Isotonicity, Sodium Acetate and Acetic Acid As Buffers, Sodium Hydroxide and/or Hydrochloric Acid To Adjust pH and Water for Injection

Other symptoms may include difficulty walking, vision problems, and mood changes